Antibodies to Saccharomyces cerevisiae in Crohns disease: Higher titers are associated with a greater frequency of mutant NOD2/CARD15 alleles and with a higher probability of complicated disease

Themistocles Dassopoulos, Constantine Frangakis, Marcia Cruz-Correa, Monica V. Talor, C. Lynne Burek, Lisa Datta, Franklin Nouvet, Theodore M Bayless, Steven R. Brant

Research output: Contribution to journalArticle

Abstract

Background: Both antibodies to Saccharomyces cerevisiae (ASCA) and carriage of two mutated NOD2/CARD15 alleles are associated with ileal Crohn's disease (CD) and complications requiring bowel surgery. We assessed the ASCA titer as a marker of CD clinical behavior. Methods: In a cross-sectional study, we phenotyped 117 unrelated CD patients. Titers (Units, U) of ASCA IgG and IgA were measured and patients were genotyped for three high-risk NOD2/CARD15 alleles. Multiple logistic regression and Cox regression analyses were used to assess the association of factors to CD phenotype and time to surgery. Results: ASCA seropositivity was associated with younger age at diagnosis, ileal disease, and complicated (stricturing or penetrating) behavior. There was a dose-response between the number of mutant NOD2/CARD15 alleles and the prevalence and titers of ASCA. The ASCA titer and tobacco use were associated with ileal disease independently of NOD2/CARD15 status. The ASCA titer (odds ratio (OR): 2.7 per 25 U, 95% confidence interval (CI): 1.5-46.7) and ileal disease were associated with stricturing/penetrating behavior, independently of NOD2/CARD15 status. Patients with ileal CD and ASCA titers of 41 U and 60 U needed 10 and 5 years of disease, respectively, to accumulate a 50% risk of complications. Conclusions: ASCA+ patients had a greater frequency of mutant NOD2/CARD15 alleles. Nonetheless, higher ASCA titers were associated with higher probabilities of ileal CD and stricturing/penetrating behavior independently of NOD2/CARD15 status. Higher ASCA titers were associated with more rapid development of complications. This quantitative marker may prove useful in risk-stratifying patients to more aggressive antiinflammatory therapies.

Original languageEnglish (US)
Pages (from-to)143-151
Number of pages9
JournalInflammatory Bowel Diseases
Volume13
Issue number2
DOIs
StatePublished - Feb 2007

Fingerprint

Crohn Disease
Saccharomyces cerevisiae
Ileal Diseases
Alleles
Antibodies
Tobacco Use
Immunoglobulin A
Anti-Inflammatory Agents
Cross-Sectional Studies
Immunoglobulin G
Logistic Models
Odds Ratio
Regression Analysis
Confidence Intervals
Phenotype

Keywords

  • ASCA
  • Crohn's disease
  • NOD2/CARD15
  • Phenotype

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Antibodies to Saccharomyces cerevisiae in Crohns disease : Higher titers are associated with a greater frequency of mutant NOD2/CARD15 alleles and with a higher probability of complicated disease. / Dassopoulos, Themistocles; Frangakis, Constantine; Cruz-Correa, Marcia; Talor, Monica V.; Burek, C. Lynne; Datta, Lisa; Nouvet, Franklin; Bayless, Theodore M; Brant, Steven R.

In: Inflammatory Bowel Diseases, Vol. 13, No. 2, 02.2007, p. 143-151.

Research output: Contribution to journalArticle

@article{9ba7c81bee37427187abfd0cd66f98bf,
title = "Antibodies to Saccharomyces cerevisiae in Crohns disease: Higher titers are associated with a greater frequency of mutant NOD2/CARD15 alleles and with a higher probability of complicated disease",
abstract = "Background: Both antibodies to Saccharomyces cerevisiae (ASCA) and carriage of two mutated NOD2/CARD15 alleles are associated with ileal Crohn's disease (CD) and complications requiring bowel surgery. We assessed the ASCA titer as a marker of CD clinical behavior. Methods: In a cross-sectional study, we phenotyped 117 unrelated CD patients. Titers (Units, U) of ASCA IgG and IgA were measured and patients were genotyped for three high-risk NOD2/CARD15 alleles. Multiple logistic regression and Cox regression analyses were used to assess the association of factors to CD phenotype and time to surgery. Results: ASCA seropositivity was associated with younger age at diagnosis, ileal disease, and complicated (stricturing or penetrating) behavior. There was a dose-response between the number of mutant NOD2/CARD15 alleles and the prevalence and titers of ASCA. The ASCA titer and tobacco use were associated with ileal disease independently of NOD2/CARD15 status. The ASCA titer (odds ratio (OR): 2.7 per 25 U, 95{\%} confidence interval (CI): 1.5-46.7) and ileal disease were associated with stricturing/penetrating behavior, independently of NOD2/CARD15 status. Patients with ileal CD and ASCA titers of 41 U and 60 U needed 10 and 5 years of disease, respectively, to accumulate a 50{\%} risk of complications. Conclusions: ASCA+ patients had a greater frequency of mutant NOD2/CARD15 alleles. Nonetheless, higher ASCA titers were associated with higher probabilities of ileal CD and stricturing/penetrating behavior independently of NOD2/CARD15 status. Higher ASCA titers were associated with more rapid development of complications. This quantitative marker may prove useful in risk-stratifying patients to more aggressive antiinflammatory therapies.",
keywords = "ASCA, Crohn's disease, NOD2/CARD15, Phenotype",
author = "Themistocles Dassopoulos and Constantine Frangakis and Marcia Cruz-Correa and Talor, {Monica V.} and Burek, {C. Lynne} and Lisa Datta and Franklin Nouvet and Bayless, {Theodore M} and Brant, {Steven R.}",
year = "2007",
month = "2",
doi = "10.1002/ibd.20031",
language = "English (US)",
volume = "13",
pages = "143--151",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Antibodies to Saccharomyces cerevisiae in Crohns disease

T2 - Higher titers are associated with a greater frequency of mutant NOD2/CARD15 alleles and with a higher probability of complicated disease

AU - Dassopoulos, Themistocles

AU - Frangakis, Constantine

AU - Cruz-Correa, Marcia

AU - Talor, Monica V.

AU - Burek, C. Lynne

AU - Datta, Lisa

AU - Nouvet, Franklin

AU - Bayless, Theodore M

AU - Brant, Steven R.

PY - 2007/2

Y1 - 2007/2

N2 - Background: Both antibodies to Saccharomyces cerevisiae (ASCA) and carriage of two mutated NOD2/CARD15 alleles are associated with ileal Crohn's disease (CD) and complications requiring bowel surgery. We assessed the ASCA titer as a marker of CD clinical behavior. Methods: In a cross-sectional study, we phenotyped 117 unrelated CD patients. Titers (Units, U) of ASCA IgG and IgA were measured and patients were genotyped for three high-risk NOD2/CARD15 alleles. Multiple logistic regression and Cox regression analyses were used to assess the association of factors to CD phenotype and time to surgery. Results: ASCA seropositivity was associated with younger age at diagnosis, ileal disease, and complicated (stricturing or penetrating) behavior. There was a dose-response between the number of mutant NOD2/CARD15 alleles and the prevalence and titers of ASCA. The ASCA titer and tobacco use were associated with ileal disease independently of NOD2/CARD15 status. The ASCA titer (odds ratio (OR): 2.7 per 25 U, 95% confidence interval (CI): 1.5-46.7) and ileal disease were associated with stricturing/penetrating behavior, independently of NOD2/CARD15 status. Patients with ileal CD and ASCA titers of 41 U and 60 U needed 10 and 5 years of disease, respectively, to accumulate a 50% risk of complications. Conclusions: ASCA+ patients had a greater frequency of mutant NOD2/CARD15 alleles. Nonetheless, higher ASCA titers were associated with higher probabilities of ileal CD and stricturing/penetrating behavior independently of NOD2/CARD15 status. Higher ASCA titers were associated with more rapid development of complications. This quantitative marker may prove useful in risk-stratifying patients to more aggressive antiinflammatory therapies.

AB - Background: Both antibodies to Saccharomyces cerevisiae (ASCA) and carriage of two mutated NOD2/CARD15 alleles are associated with ileal Crohn's disease (CD) and complications requiring bowel surgery. We assessed the ASCA titer as a marker of CD clinical behavior. Methods: In a cross-sectional study, we phenotyped 117 unrelated CD patients. Titers (Units, U) of ASCA IgG and IgA were measured and patients were genotyped for three high-risk NOD2/CARD15 alleles. Multiple logistic regression and Cox regression analyses were used to assess the association of factors to CD phenotype and time to surgery. Results: ASCA seropositivity was associated with younger age at diagnosis, ileal disease, and complicated (stricturing or penetrating) behavior. There was a dose-response between the number of mutant NOD2/CARD15 alleles and the prevalence and titers of ASCA. The ASCA titer and tobacco use were associated with ileal disease independently of NOD2/CARD15 status. The ASCA titer (odds ratio (OR): 2.7 per 25 U, 95% confidence interval (CI): 1.5-46.7) and ileal disease were associated with stricturing/penetrating behavior, independently of NOD2/CARD15 status. Patients with ileal CD and ASCA titers of 41 U and 60 U needed 10 and 5 years of disease, respectively, to accumulate a 50% risk of complications. Conclusions: ASCA+ patients had a greater frequency of mutant NOD2/CARD15 alleles. Nonetheless, higher ASCA titers were associated with higher probabilities of ileal CD and stricturing/penetrating behavior independently of NOD2/CARD15 status. Higher ASCA titers were associated with more rapid development of complications. This quantitative marker may prove useful in risk-stratifying patients to more aggressive antiinflammatory therapies.

KW - ASCA

KW - Crohn's disease

KW - NOD2/CARD15

KW - Phenotype

UR - http://www.scopus.com/inward/record.url?scp=34249313972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249313972&partnerID=8YFLogxK

U2 - 10.1002/ibd.20031

DO - 10.1002/ibd.20031

M3 - Article

C2 - 17206688

AN - SCOPUS:34249313972

VL - 13

SP - 143

EP - 151

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

SN - 1078-0998

IS - 2

ER -